LABORATOIRE SOGEVAL - Resultados de la búsqueda

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

atropine sulfate aguettant 0.1 mg/ml solution for injection in pre-filled syringe

laboratoire aguettant - atropine sulfate monohydrate - solution for injection in pre-filled syringe - 0.1 milligram(s)/millilitre - belladonna alkaloids, tertiary amines; atropine - belladonna alkaloids, tertiary amines - atropine sulfate aguettant 0.1 mg/ml, solution for injection in pre-filled syringe is indicated in adults and in paediatric population from birth, but with a body weight superior to 3 kg - as a pre-anaesthetic medication to prevent vagal reactions associated with tracheal intubation and surgical manipulation, - to limit the muscarinic effects of neostigmine, when given postsurgically to counteract non-depolarising muscle relaxants - treatment of hemodynamically compromising bradycardia and/ or atrioventricular block due to excessive vagal tone in emergency situation - cardiopulmonary resuscitation: to treat symptomatic bradycardia and av block - as antidote following overdosage or poisoning with acetylcholinesterase-inhibitors e.g. anticholinesterases, organophosphorus, carbamates and muscarinic mushrooms

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

phenylephrine 50 micrograms/ml, solution for injection in pre-filled syringe

laboratoire aguettant - phenylephrine hydrochloride - solution for injection in pre-filled syringe - 50 microgram(s)/millilitre - adrenergic and dopaminergic agents; phenylephrine - adrenergic and dopaminergic agent - treatment of hypotension during spinal, epidural or general anesthesia

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

testogel 16.2 mg/g, gel

laboratoires besins international - testosterone - gel - 16.2 milligram(s)/gram - 3-oxoandrosten (4) derivatives; testosterone - androgens. - testogel 16.2 mg/g is indicated in adults as testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests